Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 Dec 2023
Historique:
received: 26 02 2023
accepted: 01 12 2023
medline: 8 12 2023
pubmed: 8 12 2023
entrez: 7 12 2023
Statut: epublish

Résumé

The current global pandemic of COVID-19 is characterized by waves of infection due to the emergence of new SARS-CoV-2 variants carrying mutations on the Spike (S) protein gene. Since autumn 2020 many Variants of Concern (VOC) have been reported: Alpha/B.1.1.7, Beta/B.1.351, Gamma/P.1, Delta/B.1.617.2, Omicron/B.1.1.529, and sublineages. Surveillance of genomic variants is currently based on whole-genome sequencing (WGS) of viral genomes on a random fraction of samples positive to molecular tests. WGS involves high costs, extended analysis time, specialized staff, and expensive instruments compared to a PCR-based test. To rapidly identify the VOCs in positive samples, six assays based on real-time PCR and high-resolution melting (HRM) were designed on the S gene and applied to 120 oro/nasopharyngeal swab samples collected from October 2020 to June 2022 (106 positive and 14 negative samples). Overall, the assays showed 100% specificity and sensitivity compared with commercial PCR tests for COVID-19. Moreover, 104 samples out of 106 (98.1%) were correctly identified as follows: 8 Wuhan (wild type), 12 Alpha, 23 Delta, 46 Omicron BA.1/BA.1.1, 15 Omicron BA.2/BA.4/BA.5. With our lab equipment, about 10 samples can be processed every 3 h at the cost of less than € 10 ($ 10.60) per sample, including RNA extraction. The implementation of this approach could help local epidemiological surveillance and clinical decision-making.

Identifiants

pubmed: 38062105
doi: 10.1038/s41598-023-48929-1
pii: 10.1038/s41598-023-48929-1
pmc: PMC10703772
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21598

Informations de copyright

© 2023. The Author(s).

Références

Sci Rep. 2018 Jul 4;8(1):10097
pubmed: 29973679
Elife. 2020 Oct 28;9:
pubmed: 33112236
J Virol Methods. 2013 May;189(2):265-70
pubmed: 23499313
Science. 2021 Mar 12;371(6534):1152-1153
pubmed: 33514629
J Clin Microbiol. 2016 Dec 28;55(1):122-133
pubmed: 27795333
Acta Trop. 2020 Jan;201:105178
pubmed: 31606374
BMC Bioinformatics. 2012 Jun 18;13:134
pubmed: 22708584
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
J Clin Microbiol. 2022 May 18;60(5):e0017822
pubmed: 35465708
J Infect Chemother. 2021 Sep;27(9):1336-1341
pubmed: 34154921
Biochem Biophys Res Commun. 2022 May 28;606:128-134
pubmed: 35349821
Virus Genes. 2022 Aug;58(4):319-326
pubmed: 35536436
Heliyon. 2021 Sep;7(9):e07936
pubmed: 34514180
Emerg Infect Dis. 2021 Jun;27(6):1673-1676
pubmed: 33784237
Microbiol Spectr. 2022 Aug 31;10(4):e0136722
pubmed: 35861527
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478625
BMJ. 2021 Jan 26;372:n230
pubmed: 33500262
Front Biosci (Landmark Ed). 2022 Feb 14;27(2):65
pubmed: 35227008
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
Nat Methods. 2023 Apr;20(4):512-522
pubmed: 36823332
Parasit Vectors. 2023 Aug 14;16(1):282
pubmed: 37580789
Int Immunopharmacol. 2022 Apr;105:108565
pubmed: 35123183
Sci Rep. 2018 Jan 18;8(1):1114
pubmed: 29348433
AIDS Res Hum Retroviruses. 2010 Aug;26(8):913-8
pubmed: 20666583
Anal Chem. 2023 Jan 12;:
pubmed: 36633573
Antivir Ther. 2012;17(2):291-303
pubmed: 22301217
Microorganisms. 2020 Dec 16;8(12):
pubmed: 33339158
Ann Ig. 2017 Jul-Aug;29(4):293-316
pubmed: 28569339
Pharmacogenomics. 2007 Jun;8(6):597-608
pubmed: 17559349
PLoS One. 2014 Feb 13;9(2):e88845
pubmed: 24551178
J Clin Microbiol. 2010 Mar;48(3):697-702
pubmed: 20053863
Microbiol Spectr. 2023 Sep 7;:e0506422
pubmed: 37676038
Viruses. 2022 Mar 22;14(4):
pubmed: 35458383
Front Immunol. 2022 Jan 27;13:825256
pubmed: 35154144
Nat Commun. 2020 Dec 9;11(1):6272
pubmed: 33298935
Diagn Microbiol Infect Dis. 2020 Aug;97(4):115076
pubmed: 32521424
Nature. 2021 May;593(7857):136-141
pubmed: 33706364
Parasit Vectors. 2017 May 16;10(1):239
pubmed: 28511704
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
Nat Commun. 2022 May 18;13(1):2745
pubmed: 35585202
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147

Auteurs

Aurora Diotallevi (A)

Section of Biotechnology, Department of Biomolecular Sciences, University of Urbino Carlo Bo, 60132, Fano, PU, Italy. aurora.diotallevi@uniurb.it.

Gloria Buffi (G)

Section of Biotechnology, Department of Biomolecular Sciences, University of Urbino Carlo Bo, 60132, Fano, PU, Italy.

Simone Barocci (S)

Department of Clinical Pathology, Azienda Sanitaria Territoriale (AST) Pesaro e Urbino, Marche, 61029, Urbino, PU, Italy.

Marcello Ceccarelli (M)

Section of Biotechnology, Department of Biomolecular Sciences, University of Urbino Carlo Bo, 60132, Fano, PU, Italy.
Department of Clinical Pathology, Azienda Sanitaria Territoriale (AST) Pesaro e Urbino, Marche, 61029, Urbino, PU, Italy.

Daniela Bencardino (D)

Section of Biotechnology, Department of Biomolecular Sciences, University of Urbino Carlo Bo, 60132, Fano, PU, Italy.

Francesca Andreoni (F)

Section of Biotechnology, Department of Biomolecular Sciences, University of Urbino Carlo Bo, 60132, Fano, PU, Italy.
Department of Clinical Pathology, Azienda Sanitaria Territoriale (AST) Pesaro e Urbino, Marche, 61029, Urbino, PU, Italy.

Chiara Orlandi (C)

Section of Biotechnology, Department of Biomolecular Sciences, University of Urbino Carlo Bo, 60132, Fano, PU, Italy.

Marilisa Ferri (M)

Department of Clinical Pathology, Azienda Sanitaria Territoriale (AST) Pesaro e Urbino, Marche, 61029, Urbino, PU, Italy.

Daniela Vandini (D)

Department of Clinical Pathology, Azienda Sanitaria Territoriale (AST) Pesaro e Urbino, Marche, 61029, Urbino, PU, Italy.

Stefano Menzo (S)

Virology Laboratory, Azienda Ospedaliero Universitaria delle Marche, 60126, Ancona, AN, Italy.

Eugenio Carlotti (E)

Department of Prevention, Azienda Sanitaria Territoriale (AST) Pesaro e Urbino Marche, 61029, Urbino, PU, Italy.

Anna Casabianca (A)

Section of Biotechnology, Department of Biomolecular Sciences, University of Urbino Carlo Bo, 60132, Fano, PU, Italy.

Mauro Magnani (M)

Section of Biotechnology, Department of Biomolecular Sciences, University of Urbino Carlo Bo, 60132, Fano, PU, Italy.

Luca Galluzzi (L)

Section of Biotechnology, Department of Biomolecular Sciences, University of Urbino Carlo Bo, 60132, Fano, PU, Italy.

Classifications MeSH